Literature DB >> 32497001

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea.

Mi Seon Han, Moon-Woo Seong, Namhee Kim, Sue Shin, Sung Im Cho, Hyunwoong Park, Taek Soo Kim, Sung Sup Park, Eun Hwa Choi.   

Abstract

Along with positive SARS-CoV-2 RNA in nasopharyngeal swabs, viral RNA was detectable at high concentration for >3 weeks in fecal samples from 12 mildly symptomatic and asymptomatic children with COVID-19 in Seoul, South Korea. Saliva also tested positive during the early phase of infection. If proven infectious, feces and saliva could serve as transmission sources.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; Seoul; South Korea; children; coronavirus; coronavirus disease; feces; respiratory infections; saliva; severe acute respiratory syndrome coronavirus 2; viral load; viruses; zoonoses

Mesh:

Substances:

Year:  2020        PMID: 32497001      PMCID: PMC7510743          DOI: 10.3201/eid2610.202449

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


In the current pandemic of coronavirus disease (COVID-19), detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children suspected of having the disease is essential for both infection control and establishing a definite causal relationship in unprecedented cases (,). However, efforts are hindered by negative SARS-CoV-2 test results for respiratory specimens and possible cross-reactivity with other coronaviruses among seropositive cases (,). Little is known about the value of various samples other than nasopharyngeal or oropharyngeal swab specimens in diagnosing COVID-19 and understanding the viral dynamics of SARS-CoV-2 in children. Virus RNA was persistently detected in rectal swab specimens in a previous study, although the infectiousness of the virus is unknown (). We analyzed the viral RNA load kinetics of SARS-CoV-2 in various clinical specimens in children with COVID-19. In South Korea, all confirmed case-patients, regardless of disease severity, must be isolated in hospitals or isolation facilities. For this study, we included all children <18 years of age who were confirmed to have COVID-19 by positive results for SARS-CoV-2 in combined nasopharyngeal and oropharyngeal swab specimens and who were hospitalized in Seoul Metropolitan Government–Seoul National University Boramae Medical Center during March 8–April 28, 2020. We extracted RNA from clinical specimens and detected SARS-CoV-2 by using the Allplex 2019-nCoV Assay kit (Seegene, http://www.seegene.com). We performed quantitation of the viral RNA with a standard curve constructed using in vitro transcribed RNA. This study was approved by the institutional review board at SMG-SNU Boramae Medical Center; written consent was waived. We included 12 children in the study; 9 were mildly symptomatic and 3 were asymptomatic (Appendix Table 1). Median age was 6.5 years (range 27 days–16 years). Nasopharyngeal swab specimens tested positive for SARS-CoV-2 RNA in all 12 children, and 11 (92%) had positive RNA in their fecal specimens (Appendix Table 2). We collected saliva samples from 11 children; 8 (73%) tested positive. Viral RNA load in the nasopharyngeal swabs peaked early at median 7.56 (range 6.19–10.56) log10 copies/mL and decreased over time (p<0.001 for trend) (Figure, panel A). The positivity of the specimens was 75% during week 2 and 55% during week 3 (Appendix Table 2). In comparison, the median initial fecal RNA load was 7.68 (range <4.10–10.27) log10 copies/mL and remained steadily high (p = 0.148 for trend) for >3 weeks (Figure, panel B). Fecal positivity remained >80%. The median RNA load in fecal samples was significantly higher than that for nasopharyngeal swab specimens during week 2 (7.26 vs. 6.19 log10 copies/mL; p = 0.006) and week 3 (7.61 versus 5.49 log10 copies/mL; p = 0.006). Except for 1 case, the RNA load in saliva declined rapidly with time (p = 0.003 for trend) (Figure, panel C). Positivity in saliva samples was 80% in week 1 but dropped sharply to 33% in week 2 and 11% in week 3.
Figure

Changes in severe acute respiratory syndrome coronavirus 2 viral RNA load in A) nasopharyngeal swabs, B) feces, and C) saliva of mildly symptomatic and asymptomatic children with coronavirus disease over time, South Korea. The thick red line indicates trend in viral RNA load over time, and the shaded areas represent 95% CIs. The dashed line indicates the detection limit (1.25 × 104 copies/mL). Specimens with undetectable viral RNA loads are shown under the dashed line. Days after onset indicates days after symptom onset for symptomatic patients, days after diagnosis for asymptomatic patients.

Changes in severe acute respiratory syndrome coronavirus 2 viral RNA load in A) nasopharyngeal swabs, B) feces, and C) saliva of mildly symptomatic and asymptomatic children with coronavirus disease over time, South Korea. The thick red line indicates trend in viral RNA load over time, and the shaded areas represent 95% CIs. The dashed line indicates the detection limit (1.25 × 104 copies/mL). Specimens with undetectable viral RNA loads are shown under the dashed line. Days after onset indicates days after symptom onset for symptomatic patients, days after diagnosis for asymptomatic patients. We collected urine specimens from the 12 patients after a median of 3 (range 0–8) days and plasma specimens at 2 (range 0–8) days from onset. Of these, urine samples of 2 (17%) patients tested positive (median load 5.69 [range 3.82–7.55] log10 copies/mL). Only 1 (8%) patient, 27 days of age, had RNA detected in plasma. Symptomatic children had higher initial RNA load in nasopharyngeal swab specimens than asymptomatic children (9.01 vs. 6.32 log10 copies/mL; p = 0.048). We observed no significant differences in feces and in saliva and no correlation between RNA load and age. In this study, we detected SARS-CoV-2 RNA in feces of 92% of mildly ill or asymptomatic children with COVID-19. In addition, the RNA load in feces remained steadily high, whereas that in nasopharyngeal swab specimens and saliva declined with time in both symptomatic and asymptomatic children. The detection of SARS-CoV-2 RNA in feces does not necessarily mean that infectious virus is present; thus, lack of virus isolation in our study limits interpretation in the context of infectivity. However, viable virus was isolated in feces in previous studies, and infectivity was dependent on viral RNA load (,,). Considering these findings, proper handwashing when changing diapers in infants and adequate hygiene measures in restrooms are recommended to prevent the potential spread of the virus among household contacts. Our findings also suggest that feces is a promising and reliable source for detecting both current and recent SARS-CoV-2 infection because the viral RNA is present in high loads for a prolonged time. Fecal specimens could aid in seeking the etiologic relationship between COVID-19 and unexpected manifestations in children. We also detected SARS-CoV-2 RNA in saliva during the early phase of the infection for a short period of time. Live virus was isolated in saliva in a previous study, and the possibility of airborne transmission of the virus through normal speaking has been raised (,). Although the viral load in saliva drops rapidly, our findings suggest the necessity for children to wear masks, especially in schools, where children would talk in close proximity.

Appendix

Additional information about the study of viral RNA load in children with COVID-19 in Seoul.
  8 in total

1.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

2.  Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19.

Authors:  Fei Xiao; Jing Sun; Yonghao Xu; Fang Li; Xiaofang Huang; Heying Li; Jingxian Zhao; Jicheng Huang; Jincun Zhao
Journal:  Emerg Infect Dis       Date:  2020-05-18       Impact factor: 6.883

3.  The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission.

Authors:  Valentyn Stadnytskyi; Christina E Bax; Adriaan Bax; Philip Anfinrud
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-13       Impact factor: 11.205

4.  Hyperinflammatory shock in children during COVID-19 pandemic.

Authors:  Shelley Riphagen; Xabier Gomez; Carmen Gonzalez-Martinez; Nick Wilkinson; Paraskevi Theocharis
Journal:  Lancet       Date:  2020-05-07       Impact factor: 79.321

5.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

Authors:  Lucio Verdoni; Angelo Mazza; Annalisa Gervasoni; Laura Martelli; Maurizio Ruggeri; Matteo Ciuffreda; Ezio Bonanomi; Lorenzo D'Antiga
Journal:  Lancet       Date:  2020-05-13       Impact factor: 79.321

6.  Evidence for Gastrointestinal Infection of SARS-CoV-2.

Authors:  Fei Xiao; Meiwen Tang; Xiaobin Zheng; Ye Liu; Xiaofeng Li; Hong Shan
Journal:  Gastroenterology       Date:  2020-03-03       Impact factor: 22.682

7.  Consistent Detection of 2019 Novel Coronavirus in Saliva.

Authors:  Kelvin Kai-Wang To; Owen Tak-Yin Tsang; Cyril Chik-Yan Yip; Kwok-Hung Chan; Tak-Chiu Wu; Jacky Man-Chun Chan; Wai-Shing Leung; Thomas Shiu-Hong Chik; Chris Yau-Chung Choi; Darshana H Kandamby; David Christopher Lung; Anthony Raymond Tam; Rosana Wing-Shan Poon; Agnes Yim-Fong Fung; Ivan Fan-Ngai Hung; Vincent Chi-Chung Cheng; Jasper Fuk-Woo Chan; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

8.  Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.

Authors:  Yi Xu; Xufang Li; Bing Zhu; Huiying Liang; Chunxiao Fang; Yu Gong; Qiaozhi Guo; Xin Sun; Danyang Zhao; Jun Shen; Huayan Zhang; Hongsheng Liu; Huimin Xia; Jinling Tang; Kang Zhang; Sitang Gong
Journal:  Nat Med       Date:  2020-03-13       Impact factor: 87.241

  8 in total
  65 in total

1.  Wastewater-Based Estimation of the Effective Reproductive Number of SARS-CoV-2.

Authors:  Jana S Huisman; Jérémie Scire; Lea Caduff; Xavier Fernandez-Cassi; Pravin Ganesanandamoorthy; Anina Kull; Andreas Scheidegger; Elyse Stachler; Alexandria B Boehm; Bridgette Hughes; Alisha Knudson; Aaron Topol; Krista R Wigginton; Marlene K Wolfe; Tamar Kohn; Christoph Ort; Tanja Stadler; Timothy R Julian
Journal:  Environ Health Perspect       Date:  2022-05-26       Impact factor: 11.035

2.  Application of human RNase P normalization for the realistic estimation of SARS-CoV-2 viral load in wastewater: A perspective from Qatar wastewater surveillance.

Authors:  Shimaa S El-Malah; Jayaprakash Saththasivam; Khadeeja Abdul Jabbar; Arun K K; Tricia A Gomez; Ayeda A Ahmed; Yasmin A Mohamoud; Joel A Malek; Laith J Abu Raddad; Hussein A Abu Halaweh; Roberto Bertollini; Jenny Lawler; Khaled A Mahmoud
Journal:  Environ Technol Innov       Date:  2022-06-22

3.  Saliva testing for severe acute respiratory syndrome coronavirus 2 in children.

Authors:  Vanessa Clifford; Nigel Curtis
Journal:  Clin Microbiol Infect       Date:  2021-06-06       Impact factor: 13.310

4.  Saliva Is a Promising Alternative Specimen for the Detection of SARS-CoV-2 in Children and Adults.

Authors:  Rebecca Yee; Thao T Truong; Pia S Pannaraj; Natalie Eubanks; Emily Gai; Jaycee Jumarang; Lauren Turner; Ariana Peralta; Yesun Lee; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

Review 5.  An evidence review of face masks against COVID-19.

Authors:  Jeremy Howard; Austin Huang; Zhiyuan Li; Zeynep Tufekci; Vladimir Zdimal; Helene-Mari van der Westhuizen; Arne von Delft; Amy Price; Lex Fridman; Lei-Han Tang; Viola Tang; Gregory L Watson; Christina E Bax; Reshama Shaikh; Frederik Questier; Danny Hernandez; Larry F Chu; Christina M Ramirez; Anne W Rimoin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

Review 6.  Saliva Exhibits High Sensitivity and Specificity for the Detection of SARS-COV-2.

Authors:  Ibrahim Warsi; Zohaib Khurshid; Hamda Shazam; Muhammad Farooq Umer; Eisha Imran; Muhammad Owais Khan; Paul Desmond Slowey; J Max Goodson
Journal:  Diseases       Date:  2021-05-20

7.  Children's role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility.

Authors:  Katy A M Gaythorpe; Sangeeta Bhatia; Tara Mangal; H Juliette T Unwin; Natsuko Imai; Gina Cuomo-Dannenburg; Caroline E Walters; Elita Jauneikaite; Helena Bayley; Mara D Kont; Andria Mousa; Lilith K Whittles; Steven Riley; Neil M Ferguson
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

8.  A direct capture method for purification and detection of viral nucleic acid enables epidemiological surveillance of SARS-CoV-2.

Authors:  Subhanjan Mondal; Nathan Feirer; Michael Brockman; Melanie A Preston; Sarah J Teter; Dongping Ma; Said A Goueli; Sameer Moorji; Brigitta Saul; James J Cali
Journal:  Sci Total Environ       Date:  2021-07-07       Impact factor: 7.963

9.  Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.

Authors:  Erin Chung; Eric J Chow; Naomi C Wilcox; Roy Burstein; Elisabeth Brandstetter; Peter D Han; Kairsten Fay; Brian Pfau; Amanda Adler; Kirsten Lacombe; Christina M Lockwood; Timothy M Uyeki; Jay Shendure; Jeffrey S Duchin; Mark J Rieder; Deborah A Nickerson; Michael Boeckh; Michael Famulare; James P Hughes; Lea M Starita; Trevor Bedford; Janet A Englund; Helen Y Chu
Journal:  JAMA Pediatr       Date:  2021-10-04       Impact factor: 26.796

10.  Metrics to relate COVID-19 wastewater data to clinical testing dynamics.

Authors:  Amy Xiao; Fuqing Wu; Mary Bushman; Jianbo Zhang; Maxim Imakaev; Peter R Chai; Claire Duvallet; Noriko Endo; Timothy B Erickson; Federica Armas; Brian Arnold; Hongjie Chen; Franciscus Chandra; Newsha Ghaeli; Xiaoqiong Gu; William P Hanage; Wei Lin Lee; Mariana Matus; Kyle A McElroy; Katya Moniz; Steven F Rhode; Janelle Thompson; Eric J Alm
Journal:  medRxiv       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.